(Q39030536)

8 September 2017

Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms (English)

1 reference

8 September 2017

18

Andreas von Deimling

0 references

Jens Schittenhelm

12

object named as

Jens Schittenhelm

0 references

Pierre-Olivier Frappart

object named as

Pierre-Olivier Frappart

11

0 references

David Capper

8

object named as

David Capper

1 reference

8 September 2017

9

Gerhard Moldenhauer

1 reference

8 September 2017

10

Victor Mautner

1 reference

8 September 2017

David E Reuss

1

1 reference

8 September 2017

Antje Habel

2

1 reference

8 September 2017

Christian Hagenlocher

3

1 reference

8 September 2017

Jana Mucha

4

1 reference

8 September 2017

Ulrike Ackermann

5

1 reference

8 September 2017

Claudia Tessmer

6

1 reference

8 September 2017

Jochen Meyer

7

1 reference

8 September 2017

Christian Hartmann

13

1 reference

8 September 2017

Christian Hagel

14

1 reference

8 September 2017

Kathrin Katenkamp

15

1 reference

8 September 2017

Iver Petersen

16

1 reference

8 September 2017

Gunhild Mechtersheimer

17

1 reference

8 September 2017

language of work or name

English

0 references

publication date

25 January 2014

1 reference

8 September 2017

Acta Neuropathologica

1 reference

8 September 2017

127

1 reference

8 September 2017

4

1 reference

8 September 2017

565-572

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-014-1246-6

8 September 2017

0 references

cites work

Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Clinical and genetic aspects of neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Neoplasms associated with germline and somatic NF1 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Biomarkers for malignant peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Neurofibromin, a tumor suppressor in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

Germline and somaticNF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1246-6

10.1007/S00401-014-1246-6

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference